NanoPass Technologies Expands Product Portfolio to Advance Intradermal Delivery

NanoPass Technologies Ltd., a global leader in intradermal delivery solutions, will officially launch MicronJet™ 800 during ...

PharmaJet's Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data

Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. -- The Scancell ...
AlphaGalileo

Microneedle Technology for Overcoming Biological Barriers: Advancing Biomacromolecular Delivery in Major Diseases

Biomacromolecules are increasingly important for treating major diseases such as tumors, infections, cardiovascular diseases, metabolic disorders, ...
Cantech Letter

PharmaTher Expands PharmaPatch(TM) Platform into GLP-1 for Obesity, Leveraging Its Ketamine and Psychedelic Patch Programs

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the “Company” or “PharmaTher”), a specialty pharmaceutical company focused on unlocking ...

Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- ...

Pacira BioSciences: Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences ...